Valérie Leroy
Investor Relations Contact chez VALERIO THERAPEUTICS
Profil
Valérie Leroy is currently the Director-Investor Relations & Communications at Valerio Therapeutics SA since 2016.
Prior to this, she worked as the Director-Marketing & Investor Relations at Carmat SA and as the Head-Investor Relations & Corporate Communications at Genticel SA. Ms. Leroy graduated from the Institut d'Administration des Entreprises de Paris in 1996.
Postes actifs de Valérie Leroy
| Sociétés | Poste | Début |
|---|---|---|
| VALERIO THERAPEUTICS | Investor Relations Contact | 01/12/2016 |
Anciens postes connus de Valérie Leroy
| Sociétés | Poste | Fin |
|---|---|---|
Genticel SA
 Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Investor Relations Contact | - |
| CARMAT | Investor Relations Contact | - |
Formation de Valérie Leroy
| Institut d'Administration des Entreprises de Paris | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VALERIO THERAPEUTICS | Health Technology |
| CARMAT | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Health Technology |
